OmniVision: March 2026 Share Update Shows Stable H-Share Base, Minor A-Share Uptick from Options; Public Float at 4.02% Worth HK$5.37 Billion

Bulletin Express
04/08

OmniVision Integrated Circuits Group, Inc. released its Monthly Return for Equity Issuer for the period ended 31 March 2026, outlining modest changes in registered capital and confirming compliance with Hong Kong’s public-float requirements. Key takeaways are as follows:

1. Authorised and Issued Share Capital • Registered share capital totalled RMB 1.26 billion (1,261.07 million shares at RMB 1 par value), unchanged month-on-month. • H-share quota remained flat at 50.74 million shares, while A-share authorisations increased marginally by 23,598 shares to 1.21 billion.

2. Share Issuance and Treasury Position • Issued H shares were unchanged at 50.74 million; no treasury H shares are outstanding. • Issued A shares rose by 23,598 to 1.20641 billion, reflecting option exercises. Treasury stock was steady at 3.92 million A shares.

3. Equity Incentive Activity • Two tranches of the 2023 stock-option plans added 23,598 new A shares during the month, generating RMB 1.84 million in proceeds. • Outstanding unexercised options under all incentive schemes total 28.91 million A shares, split across: – 2023 First Phase: 3.37 million options at RMB 78.01 exercise price – 2023 Second Phase: 5.55 million options at RMB 78.01 – 2025 Plan: 19.98 million options at RMB 138.67

4. Convertible Bonds • Convertible bonds due 27 December 2026 remain unchanged at RMB 2.43 billion, carrying a conversion price of RMB 159.12 per share and potentially issuable into 15.29 million A shares; no conversions occurred in March.

5. Public Float Confirmation • The company affirmed compliance with Main Board Rule 13.32D(1). H-share public float stood at 4.02%, equivalent to HK$5.37 billion in market value—well above the HK$1 billion threshold required for PRC issuers with additional listings.

The filing, submitted on 8 April 2026 by Joint Company Secretary Ren Bing, reports no share buy-backs, warrant activity, or HDR movements during the month. Overall, OmniVision’s capital structure remained broadly stable, with incremental dilution limited to option conversions.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10